Literature DB >> 19914287

Role of BDNF and GDNF in drug reward and relapse: a review.

Udi E Ghitza1, Haifeng Zhai, Ping Wu, Mikko Airavaara, Yavin Shaham, Lin Lu.   

Abstract

Brain-derived neurotrophic factor (BDNF) and glial cell line-derived neurotrophic factor (GDNF) are neurotrophic factors that are critical for the growth, survival, and differentiation of developing neurons. These neurotrophic factors also play important roles in the survival and function of adult neurons, learning and memory, and synaptic plasticity. Since the mid-1990s, investigators have studied the role of BDNF and GDNF in the behavioral effects of abused drugs and in the neuroadaptations induced by repeated exposure to drugs in the mesocorticolimbic dopamine system. Here, we review rodent studies on the role of BDNF and GDNF in drug reward, as assessed in the drug self-administration and the conditioned place preference procedures, and in drug relapse, as assessed in extinction and reinstatement procedures. Our main conclusion is that whether BDNF or GDNF would facilitate or inhibit drug-taking behaviors depends on the drug type, the brain site, the addiction phase (initiation, maintenance, or abstinence/relapse), and the time interval between site-specific BDNF or GDNF injections and the reward- and relapse-related behavioral assessments. Published by Elsevier Ltd.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19914287      PMCID: PMC2891859          DOI: 10.1016/j.neubiorev.2009.11.009

Source DB:  PubMed          Journal:  Neurosci Biobehav Rev        ISSN: 0149-7634            Impact factor:   8.989


  173 in total

Review 1.  Neurotrophin signalling in health and disease.

Authors:  Moses V Chao; Rithwick Rajagopal; Francis S Lee
Journal:  Clin Sci (Lond)       Date:  2006-02       Impact factor: 6.124

2.  Effects of repeated morphine on locomotion, place preference and dopamine in heterozygous glial cell line-derived neurotrophic factor knockout mice.

Authors:  M Airavaara; H Tuomainen; T P Piepponen; M Saarma; L Ahtee
Journal:  Genes Brain Behav       Date:  2006-07-27       Impact factor: 3.449

3.  An inducer for glial cell line-derived neurotrophic factor and tumor necrosis factor-alpha protects against methamphetamine-induced rewarding effects and sensitization.

Authors:  Minae Niwa; Atsumi Nitta; Yuichiro Yamada; Akira Nakajima; Kuniaki Saito; Mitsuru Seishima; Liya Shen; Yukihiro Noda; Shoei Furukawa; Toshitaka Nabeshima
Journal:  Biol Psychiatry       Date:  2006-10-13       Impact factor: 13.382

4.  The effects of 6-hydroxydopamine lesions of the nucleus accumbens and the mesolimbic dopamine system on oral self-administration of ethanol in the rat.

Authors:  S Rassnick; L Stinus; G F Koob
Journal:  Brain Res       Date:  1993-09-24       Impact factor: 3.252

5.  Experimental morphine addiction: method for automatic intravenous injections in unrestrained rats.

Authors:  J R WEEKS
Journal:  Science       Date:  1962-10-12       Impact factor: 47.728

6.  Differential regulation of neurotrophin and trk receptor mRNAs in catecholaminergic nuclei during chronic opiate treatment and withdrawal.

Authors:  S Numan; S B Lane-Ladd; L Zhang; K H Lundgren; D S Russell; K B Seroogy; E J Nestler
Journal:  J Neurosci       Date:  1998-12-15       Impact factor: 6.167

Review 7.  Regulation of drug-taking and -seeking behaviors by neuroadaptations in the mesolimbic dopamine system.

Authors:  David W Self
Journal:  Neuropharmacology       Date:  2004       Impact factor: 5.250

8.  An analog of a dipeptide-like structure of FK506 increases glial cell line-derived neurotrophic factor expression through cAMP response element-binding protein activated by heat shock protein 90/Akt signaling pathway.

Authors:  Xiaobo Cen; Atsumi Nitta; Shin Ohya; Yinglan Zhao; Naoya Ozawa; Akihiro Mouri; Daisuke Ibi; Li Wang; Makiko Suzuki; Kuniaki Saito; Yasutomo Ito; Tetsuya Kawagoe; Yukihiro Noda; Yoshihisa Ito; Shoei Furukawa; Toshitaka Nabeshima
Journal:  J Neurosci       Date:  2006-03-22       Impact factor: 6.167

Review 9.  Brain dopamine and reward.

Authors:  R A Wise; P P Rompre
Journal:  Annu Rev Psychol       Date:  1989       Impact factor: 24.137

10.  A role for corticotropin releasing factor (CRF) in ethanol consumption, sensitivity, and reward as revealed by CRF-deficient mice.

Authors:  M Foster Olive; Kristin K Mehmert; Heather N Koenig; Rosana Camarini; Joseph A Kim; Michelle A Nannini; Christine J Ou; Clyde W Hodge
Journal:  Psychopharmacology (Berl)       Date:  2002-10-24       Impact factor: 4.530

View more
  81 in total

1.  Effects of A₂A adenosine receptor blockade or stimulation on alcohol intake in alcohol-preferring rats.

Authors:  Maria Vittoria Micioni Di Bonaventura; Carlo Cifani; Catia Lambertucci; Rosaria Volpini; Gloria Cristalli; Rino Froldi; Maurizio Massi
Journal:  Psychopharmacology (Berl)       Date:  2011-08-11       Impact factor: 4.530

2.  Endogenous GDNF in ventral tegmental area and nucleus accumbens does not play a role in the incubation of heroin craving.

Authors:  Mikko Airavaara; Charles L Pickens; Anna L Stern; Kristina A Wihbey; Brandon K Harvey; Jennifer M Bossert; Qing-Rong Liu; Barry J Hoffer; Yavin Shaham
Journal:  Addict Biol       Date:  2010-12-23       Impact factor: 4.280

3.  Cocaine-mediated activation of microglia and microglial MeCP2 and BDNF production.

Authors:  Bianca Cotto; Hongbo Li; Ronald F Tuma; Sara Jane Ward; Dianne Langford
Journal:  Neurobiol Dis       Date:  2018-05-30       Impact factor: 5.996

4.  Alcohol reward, dopamine depletion, and GDNF.

Authors:  Charles L Pickens; Donna J Calu
Journal:  J Neurosci       Date:  2011-10-19       Impact factor: 6.167

5.  Functional consequences of cocaine re-exposure after discontinuation of cocaine availability.

Authors:  Thomas J R Beveridge; Hilary R Smith; Susan H Nader; Michael A Nader; Linda J Porrino
Journal:  Neuropharmacology       Date:  2014-06-19       Impact factor: 5.250

6.  Lasting changes induced by mild alcohol exposure during embryonic development in BDNF, NCAM and synaptophysin-positive neurons quantified in adult zebrafish.

Authors:  Samantha Mahabir; Dipashree Chatterjee; Keith Misquitta; Diptendu Chatterjee; Robert Gerlai
Journal:  Eur J Neurosci       Date:  2018-06-15       Impact factor: 3.386

Review 7.  Sex differences in drug addiction and response to exercise intervention: From human to animal studies.

Authors:  Yuehui Zhou; Min Zhao; Chenglin Zhou; Rena Li
Journal:  Front Neuroendocrinol       Date:  2015-07-13       Impact factor: 8.606

8.  Resistance exercise decreases heroin self-administration and alters gene expression in the nucleus accumbens of heroin-exposed rats.

Authors:  Mark A Smith; Gaylen E Fronk; Jean M Abel; Ryan T Lacy; Sarah E Bills; Wendy J Lynch
Journal:  Psychopharmacology (Berl)       Date:  2018-02-02       Impact factor: 4.530

9.  GDNF and alcohol use disorder.

Authors:  Segev Barak; Somayeh Ahmadiantehrani; Marian L Logrip; Dorit Ron
Journal:  Addict Biol       Date:  2018-05-04       Impact factor: 4.280

10.  Altered serum levels of glial cell line-derived neurotrophic factor in male chronic schizophrenia patients with tardive dyskinesia.

Authors:  Fei Ye; Qiongqiong Zhan; Wenhuan Xiao; Weiwei Sha; Xiaobin Zhang
Journal:  Int J Methods Psychiatr Res       Date:  2018-06-14       Impact factor: 4.035

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.